Intellectual Property

We provide strategic legal advice on patents, including Supplementary Protection Certificates under Regulation (EC) 469/2009, regulatory data exclusivity, market exclusivity for orphan drugs and the Bolar exemption. We support patent litigation strategy under the Unified Patent Court regime under Regulation (EU) 1257/2012 and the UPC Agreement, including opt out and opt in decisions. We advise on trademarks under Regulation (EU) 2017/1001 and Directive (EU) 2015/2436 and on the Madrid System for international filings. We deliver advice on copyright under Law 2121/1993 and Directive (EU) 2019/790 (DSM Directive), on trade secrets under Law 4605/2019 (transposition of Directive (EU) 2016/943) and on regulatory data protection. We negotiate licensing, assignment, R&D, collaboration, IP escrow and material transfer agreements. We also advise on the IP framework for AI generated outputs under the AI Act and on freedom to operate analyses for emerging therapies.